Supplemental material
Open access
1,048
Views
1
CrossRef citations to date
0
Altmetric
Oncology
Tislelizumab in advanced/metastatic esophageal squamous cell carcinoma: health-related quality of life in Asian patients
Sung-Bae Kima Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
, Eric Van Cutsemb University Hospitals Gasthuisberg Leuven and KU Leuven, Leuven, Belgium
, Jaffer Ajanic University of Texas MD Anderson Cancer Center, Houston, TX, USA
, Lin Shend Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China
, Gisoo Barnese BeiGene, Ltd, Emeryville, CA, USACorrespondence[email protected]
, Ningning Dingf BeiGene (Shanghai) Co., Ltd., Shanghai, China
, Aiyang Taoe BeiGene, Ltd, Emeryville, CA, USA
, Tianyu Xiae BeiGene, Ltd, Emeryville, CA, USA
, Lin Zhane BeiGene, Ltd, Emeryville, CA, USA
& Ken Katog National Cancer Center Hospital, Tokyo, Japan
show all
Pages 69-75
|
Received 12 Jun 2023, Accepted 11 Oct 2023, Published online: 23 Nov 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.